Important pharmacy news and late-breaking industry information updated daily.

In an effort to minimize adverse drug reactions, researchers at Harvard Medical School, the Jackson Laboratory, the Massachusetts Institute of Technology, the University of Massachusetts, Northeastern University, Oracle Health Sciences, and the Novartis Institutes for Biomedical Research studied adverse drug reaction events from post-marketing identification surveys and target-based in vitro pharmacology of more than 2,000 marketed drugs.

HHS and the U.S. Department of Defense (DoD) announced Friday agreements with Sanofi and GlaxoSmithKline to support advanced development, including clinical trials and large-scale manufacturing of 100 million doses of an investigational adjuvanted vaccine against COVID-19.

The Ohio Board of Pharmacy on Thursday reversed its decision to ban sales of the drug hydroxychloroquine to treat COVID-19 after feedback from the medical community.

APhA and other leading pharmacy groups said in a letter to HHS Secretary Alex Azar that any action on a prescription drug rebate rule must address escalating fees extracted by PBMs on behalf of plan sponsors in Medicare Part D.

A retrospective cohort study examined FDA-approved vaccine labels and subsequent labeling changes triggered by post-market safety concerns. The research, covering a period of 20 years ending in December 2015, included 57 vaccines—most of which were supported by large randomized controlled trials.

Updated on July 29, 2020, at 1:25 pm.

Surprise! President Trump signed four executive orders aimed at lowering drug prices on Friday, July 24—and one of them includes a rebate reform rule long thought to be dead in the water. It’s a step forward, and APhA and other pharmacy advocates are now working on securing a meeting with the U.S. Department of Health and Human Services (HHS) Secretary to ensure it also addresses PBMs' harmful use of pharmacy direct and indirect remuneration fees (DIR) fees. DIR fees have a negative effect on pharmacy sustainability and patient access to care.

NIH and the biotech firm Moderna report the first large study of the safety and effectiveness of a coronavirus vaccine in the United States began on Monday. The study, a Phase III clinical trial, will enroll 30,000 healthy people at about 89 sites around the country this summer.

FDA announced that labeling for opioid analgesics and medicine to treat opioid use disorder (OUD) must be updated to recommend that naloxone availability be discussed as a routine part of prescribing these medications.

President Trump signed four executive orders aimed at lowering drug prices Friday. The orders are variations of drug pricing proposals the administration rolled out last year, but are largely symbolic because they are unlikely to take effect anytime soon, if they do so at all, as the power to implement drug pricing policy through executive order...

Illegitimate online pharmacies aren’t new. They’ve been endangering patients by peddling counterfeit, ineffective, improper, and tainted medications for years—some drugs contain too much or too little of the active ingredient or none of it, and some contain harmful substances like rat poison and antifreeze. According to the Alliance for Safe Online Pharmacies, up to 98% of online pharmacies violate the law.